ADVERTISEMENT
Today, at the 58th annual conference in New Orleans, Tracy Glauser, M.D., Director,Comprehensive Epilepsy Center at Cincinatti Children's Hospital presented his most recent findings on the use of levetiracetam (Keppra) as an adjunctive (add-on)...
With the staggering number of patients with epilepsy utilizing emergency department care,William Tatum, M.D.,Clinical Associate Professor at the University of South Florida, and Thomas L. Orth, Executive Director, Epilepsy Services of West Central...
“We found a 5% per year terminal remission rate in our study. One of the take home messages from our findings is that continuing to attempt to improve seizure control by changing medications is important because little by little patients can...
Today, at the 58th annual AES conference in New Orleans, Jacqueline French, M.D.,Professor of Neurology at the Hospital of the University of Pennsylvania and co-director of the epilepsy center, presented the findings from a multicenter, randomized,...
After an inspection of the manufacturing facility in Texas, the FDA recently notified Cyberonics there were problems with their production of vagus nerve stimulators (VNS). They raised concerns about the methods, the facilities and or controls...

Pages